Balitrand N - Search Results

1

The retinoic acid receptor alpha gene is rearranged in retinoic acid-sensitive promyelocytic leukemias.

Chomienne C, Ballerini P, Balitrand N, Huang ME, Krawice I, Castaigne S, Fenaux P, Tiollais P, Dejean A, Degos L, de The H. Chomienne C, et al. Among authors: balitrand n. Leukemia. 1990 Dec;4(12):802-7. Leukemia. 1990. PMID: 2173802

2

Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia.

Dubois C, Schlageter MH, de Gentile A, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, Degos L, et al. Dubois C, et al. Among authors: balitrand n. Leukemia. 1994 Oct;8(10):1750-7. Leukemia. 1994. PMID: 7523800

3

In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.

Cornic M, Delva L, Castaigne S, Lefebvre P, Balitrand N, Degos L, Chomienne C. Cornic M, et al. Among authors: balitrand n. Leukemia. 1994;8 Suppl 2:S16-9. Leukemia. 1994. PMID: 7815831 Review.

4

Differential uptake of all-trans retinoic acid by acute promyelocytic leukemic cells: evidence for its role in retinoic acid efficacy.

Agadir A, Cornic M, Lefebvre P, Gourmel B, Balitrand N, Degos L, Chomienne C. Agadir A, et al. Among authors: balitrand n. Leukemia. 1995 Jan;9(1):139-45. Leukemia. 1995. PMID: 7845008

5

Induction of high-affinity GM-CSF receptors during all-trans retinoic acid treatment of acute promyelocytic leukemia.

de Gentile A, Toubert ME, Dubois C, Krawice I, Schlageter MH, Balitrand N, Castaigne S, Degos L, Rain JD, Najean Y, et al. de Gentile A, et al. Among authors: balitrand n. Leukemia. 1994 Oct;8(10):1758-62. Leukemia. 1994. PMID: 7934172

6

In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.

Cornic M, Delva L, Castaigne S, Lefebvre P, Balitrand N, Degos L, Chomienne C. Cornic M, et al. Among authors: balitrand n. Leukemia. 1994 Jun;8(6):914-7. Leukemia. 1994. PMID: 8207983 Review.

7

Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient.

Guidez F, Huang W, Tong JH, Dubois C, Balitrand N, Waxman S, Michaux JL, Martiat P, Degos L, Chen Z, et al. Guidez F, et al. Among authors: balitrand n. Leukemia. 1994 Feb;8(2):312-7. Leukemia. 1994. PMID: 8309256

8

Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells.

Delva L, Cornic M, Balitrand N, Guidez F, Micléa JM, Delmer A, Teillet F, Fenaux P, Castaigne S, Degos L, et al. Delva L, et al. Among authors: balitrand n. Blood. 1993 Oct 1;82(7):2175-81. Blood. 1993. PMID: 8400267 Free article.

9

All-trans retinoic acid rapidly decreases cathepsin G synthesis and mRNA expression in acute promyelocytic leukemia.

Seale J, Delva L, Renesto P, Balitrand N, Dombret H, Scrobohaci ML, Degos L, Paul P, Chomienne C. Seale J, et al. Among authors: balitrand n. Leukemia. 1996 Jan;10(1):95-101. Leukemia. 1996. PMID: 8558945

10

In vitro treatment with retinoids or the topoisomerase inhibitor, VP-16, evidences different functional apoptotic pathways in acute promyelocytic leukemic cells.

Calabresse C, Barbey S, Venturini L, Balitrand N, Degos L, Fenaux P, Chomienne C. Calabresse C, et al. Among authors: balitrand n. Leukemia. 1995 Dec;9(12):2049-57. Leukemia. 1995. PMID: 8609716

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters